Dr. Paul Robert Bilovsky is a Sherman Oaks, California based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 4910 Van Nuys Blvd, Suite 102, Sherman Oaks. Patients can reach him at 818-789-6622.
Dr. Paul Robert Bilovsky deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Paul Robert Bilovsky speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Paul Robert Bilovsky
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
DDS
Accepts Medicare Assignment:
May Accept
Practice Address:
4910 Van Nuys Blvd, Suite 102, Sherman Oaks, California, 91403-1715
Phone:
818-789-6622
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
8729383591
Enrollment ID:
I20160217000496
NPI Number:
1407981939
NPI Enumeration Date:
23 Feb, 2007
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4910 Van Nuys Blvd, Suite 102 Sherman Oaks, California
Zip:
91403-1715
Phone Number:
818-789-6622
Patients can reach Dr. Paul Robert Bilovsky at 4910 Van Nuys Blvd, Suite 102, Sherman Oaks, California or can call to book an appointment on 818-789-6622. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.